Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume 31, Issue 9, Pages 1172-1181
Publisher
American Society of Clinical Oncology (ASCO)
Online
2013-02-05
DOI
10.1200/jco.2012.44.3184
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia
- (2012) A. F. T. Ribeiro et al. BLOOD
- Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML
- (2012) Z. Li et al. BLOOD
- Blockade of miR-150 Maturation by MLL-Fusion/MYC/LIN-28 Is Required for MLL-Associated Leukemia
- (2012) Xi Jiang et al. CANCER CELL
- Age-Related Prognostic Impact of Different Types ofDNMT3AMutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia
- (2012) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
- (2012) A Renneville et al. LEUKEMIA
- miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
- (2012) Zejuan Li et al. Nature Communications
- Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
- (2011) V. Rockova et al. BLOOD
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- (2011) K. H. Metzeler et al. BLOOD
- TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
- (2011) F. G. Rucker et al. BLOOD
- Diagnostic and Prognostic Value of Cytogenetics in Acute Myeloid Leukemia
- (2011) David Grimwade et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Prognosis of Acute Myeloid Leukemia According to the New Genetic Risk Classification of the European LeukemiaNet Recommendations: Evaluation of the Proposed Reporting System
- (2011) Christoph Röllig et al. JOURNAL OF CLINICAL ONCOLOGY
- TET2Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2011) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression profiling in MDS and AML: potential and future avenues
- (2011) K Theilgaard-Mönch et al. LEUKEMIA
- Predictive value of TP53 fluorescencein situhybridization in cytogenetic subgroups of acute myeloid leukemia
- (2011) Sigal Tavor et al. LEUKEMIA & LYMPHOMA
- Independent prognostic variables in acute myeloid leukaemia
- (2010) Matthew L. Smith et al. BLOOD REVIEWS
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- (2009) B. J. Wouters et al. BLOOD
- Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
- (2009) Annika Dufour et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia
- (2009) H Seifert et al. LEUKEMIA
- An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia
- (2008) K. H. Metzeler et al. BLOOD
- Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B
- (2008) R. F. Schlenk et al. HAEMATOLOGICA
- Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling
- (2008) R. G.W. Verhaak et al. HAEMATOLOGICA
- Prognostic Significance of, and Gene and MicroRNA Expression Signatures Associated With,CEBPAMutations in Cytogenetically Normal Acute Myeloid Leukemia With High-Risk Molecular Features: A Cancer and Leukemia Group B Study
- (2008) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype and is associated with very poor prognosis
- (2008) D Bowen et al. LEUKEMIA
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA Expression in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Guido Marcucci et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now